EMBL Australia

EMBL Australia group leader Dr Harald Janovjak was recently awarded a prestigious ARC Future Fellowship to develop innovative genomic tools.

Professor Ewan Birney, the Deputy Director General of EMBL and Director of EMBL-EBI, is a participant in the Oxford trial for a COVID-19 vaccine and shared his views on the global coronavirus pandemic with us.

Research by EMBL Australia alumnus Dr Nico Plachta and group leader Dr Maté Biro, and published in Nature, has led to a fundamental discovery that advances our understanding of how mammals develop in the earliest stages after fertilisation.

Associate Professor Max Cryle is an EMBL Australia Group Leader, based at the Monash Biomedicine Discovery Institute.

EMBL Australia group leader A/Prof Mikaël Martino and Victorian node head Prof Peter Currie will use a grant of more than $820,000 from the Medical Research Future Fund's Stem Cell Therapies Mission to improve the lives of those with muscular dystrophies & myopathies.

Two EMBL Australia group leaders have been awarded close to $2 million in funding for their innovative projects under the Australian Research Council’s Future Fellowships scheme.

New research from an EMBL Australia group leader outlines a novel method of enhancing regenerative activity, with clinical implications on improving the effectiveness of growth factor-based therapies.

The international research community is collaborating on a scale and at a speed never seen before to battle COVID-19 and EMBL Australia group leaders have answered the call to help.

EMBL Australia group leader Professor David Lynn will be the interim director of a new $7 million state-of-the-art centre for genomics in South Australia that he played a vital role in championing.

Professor David Lynn is an EMBL Australia Group Leader, based at the South Australian Health and Medical Research Institute (SAHMRI), and a Flinders University Professor.